Single nucleotide polymorphism to disclose severe side-effects or proper dosage for each patient.
Ichikawa
Y
Y
D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008780:Methyltransferases / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D012216:Rheumatic Diseases / Q000201:enzymology / Q000208:ethnology / Q000235:genetics; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine